valproic acid has been researched along with fluorodeoxyglucose f18 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeCarli, C; Fazilat, S; Gaillard, WD; Theodore, WH; Zeffiro, T | 1 |
Debus, O; Kurlemann, G; Löttgen, J; Matheja, P; Schober, O; Schuierer, G; Weckesser, M | 1 |
Forman, S; Kirschbaum, MH; Rotter, A; Weiss, L; Zain, J | 1 |
Tobe, E | 1 |
4 other study(ies) available for valproic acid and fluorodeoxyglucose f18
Article | Year |
---|---|
Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study.
Topics: Adult; Brain; Carbamazepine; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Oxygen Radioisotopes; Phenobarbital; Phenytoin; Tomography, Emission-Computed; Valproic Acid; Water | 1996 |
Drug-induced changes in cerebral glucose consumption in bifrontal epilepsy.
Topics: Anticonvulsants; Carbamazepine; Cerebral Cortex; Child, Preschool; Cysteine; Electroencephalography; Epilepsies, Partial; Epilepsy, Frontal Lobe; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Valproic Acid | 2000 |
Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Recurrence; Remission Induction; Treatment Failure; Valproic Acid | 2007 |
Progressive neuropsychiatric and brain abnormalities after smoke inhalation.
Topics: Activities of Daily Living; Brain; Cognition Disorders; Depressive Disorder, Major; DNA Damage; Fluorodeoxyglucose F18; Fructose; Humans; Male; Memory, Long-Term; Methylphenidate; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Sertraline; Smoke Inhalation Injury; Time Factors; Topiramate; Valproic Acid | 2012 |